Vaxart, inc. (VXRT)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

-1,297

-6,409

-5,260

-5,637

-1,339

-4,902

-6,548

-8,871

2,314

-3,400

-5,300

-3,538

-2,796

-9,100

-10,000

-7,000

-5,200

-6,600

-6,600

-19,900

1,200

6,500

-6,900

-10,200

3,200

-100

-3,900

-6,500

200

4,600

-7,200

-2,733

-436

-11,330

78

-4,599

1,980

Adjustments to reconcile net loss to net cash used in operating activities:
Bargain purchase gain

-

-

-

-

-

100

0

-328

6,988

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

580

742

757

997

1,100

824

942

926

511

85

92

106

97

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Gain) loss on sale of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-18

0

0

-29

Income from discontinued operations, net of tax provision

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

991

-

-

-

-

Net loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,090

-2,733

-1,427

-1,990

-2,904

-4,599

1,980

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

300

400

400

1,000

400

500

500

600

900

900

600

17

17

1,497

20

45

65

Non-cash intra-period tax allocation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-671

-

-

-

-

Stock-based compensation

96

137

146

180

164

152

183

118

86

300

500

129

124

500

400

400

400

600

600

500

600

600

400

300

500

600

300

300

400

1,700

200

658

976

-517

796

645

570

Loss on revaluation of financial instruments

-

-

-

-

-

0

0

0

-3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of discount on short-term investments

-

-

-

-

-

-

-

-

-

4

8

7

5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss (gain) on revaluation of financial instruments, net

-

-

-

-

-

-

-

-

-

2,381

464

321

181

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

-

-5

29

29

35

40

42

43

323

639

638

629

651

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of note discount

-

-

-

-

-

0

0

0

18

37

36

35

36

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash royalty revenue related to sale of future royalties

-

-

-

-

-

-

-

-

-

-

100

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense related to sale of future royalties

491

513

500

516

544

561

532

468

298

400

400

400

500

500

400

300

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense related to sale of future royalties

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash revenue related to sale of future royalties

2,769

335

15

1,748

1,384

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,100

0

-500

100

-

-

-

-

-

-

Change in operating assets and liabilities:
Accounts receivable

-956

3,060

524

-5,549

3,788

1,540

-305

-12,788

-1,947

200

-500

-1,275

770

1,400

0

-9,400

5,000

1,900

-9,400

-400

-3,800

-1,400

-600

-18,200

8,600

14,700

2,000

-4,500

3,300

4,200

1,200

-

-

-

-

-

-

Receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

-128

-867

104

165

-5,754

5,450

Prepaid expenses and other assets

690

-691

366

-430

-100

457

-32

-21

469

200

-400

-150

187

-1,100

1,200

1,300

-100

700

200

-300

-100

500

-200

-100

-100

-300

-900

200

-700

1,000

100

83

-279

1,242

-1,121

386

31

Accounts payable

-55

-198

483

-163

-184

-289

-236

-162

-3,097

601

-511

-225

-1,424

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other accrued liabilities

-520

-

-

-

99

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

-

-

-

-

-

-2

-698

-157

-5,536

-144

-108

6

169

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable, accrued expenses and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,560

419

-924

-3,483

-1,256

1,380

-2,499

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-100

0

0

-200

-300

-200

500

-100

-631

-632

984

-631

-3,267

-3,267

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

1,000

-900

-500

-4,200

1,700

-300

-600

2,700

-500

-2,300

3,300

-5,400

-8,000

-5,700

100

6,300

5,200

-1,000

4,400

-1,800

-2,500

2,700

-

-

-

-

-

-

Accrued severance obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-600

1,200

-1,200

-200

-800

-1,400

-500

-500

0

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,100

-7,000

-9,100

900

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-3,208

-3,792

-4,328

-317

-4,653

-5,702

-5,358

7,102

-10,590

-4,700

-4,500

-1,747

-4,276

-9,000

-10,700

-

-

-

-

-

800

1,000

-11,600

-

700

-8,400

-6,200

2,500

-3,600

-7,600

-5,200

-2,225

-1,515

-7,582

-5,428

-428

-8,603

Cash flows from investing activities:
Purchase of property and equipment

4

12

127

159

552

195

173

199

140

41

-19

16

79

-

-

-

-

-

-

-

-

-

-

-100

100

0

100

500

100

200

200

-

-

-

-

-

-

Call redemption of long-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

6,900

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales and maturities of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1

2,080

6,944

7,645

38,199

13,836

Proceeds from sale of equipment

3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash acquired in reverse merger

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash acquired in reverse merger

-

-

-

-

-

0

0

0

25,525

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for fractional shares in merger

-

-

-

-

-

0

0

0

21

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of short-term investments

-

-

-

-

-

0

0

0

573

0

7,000

1,335

4,430

8,400

0

1,800

7,100

5,200

1,200

7,800

0

0

9,900

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturities of short-term investments

-

-

-

-

-

0

0

0

1,988

14,500

13,400

2,398

3,665

9,700

6,900

1,200

5,900

8,000

1,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1,300

2,800

-200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-1

-12

-127

-159

-552

-195

-173

-199

26,779

14,500

6,400

1,047

-844

1,300

6,900

-

-

-

-

-

300

6,900

-9,900

-

-100

0

-100

-500

-100

32,500

-200

-1

2,080

-12,496

11,637

27,724

13,836

Net proceeds from issuance of securities in registered direct offering

9,175

0

0

0

2,540

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17

121

230

295

Proceeds from issuance of common stock upon exercise of common stock warrants

10,349

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of short-term note

-

-

-

-

-

102

51

-217

278

0

0

0

0

-

-

100

100

0

100

100

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock upon exercise of stock options

18

-

-

-

-

0

0

0

13

24

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of principal on secured promissory note payable to Oxford Finance

-

2,549

417

416

417

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,000

-100

0

-100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

19,542

-2,228

7,755

8,310

2,123

-519

-468

-477

-265

0

0

0

0

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

17

121

230

295

Net increase (decrease) in cash and cash equivalents

16,333

-6,032

3,300

7,834

-3,082

-6,416

-5,999

6,426

15,924

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

9,800

1,900

-700

-5,120

-7,800

-3,800

19,100

-8,400

-6,300

600

-16,600

1,100

7,900

-21,500

700

27,400

-8,400

-6,300

2,000

-3,700

24,900

-5,400

-2,226

565

-20,199

6,330

27,526

5,528

Effects of exchange rate movements on cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-200

-3,300

-1,900

-2,500

900

1,300

-1,000

300

-5,500

-100

2,100

-1,300

-

-

-

-

-

-

Supplemental disclosure of cash flow information:
Interest paid

-

32

59

64

72

80

87

94

95

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

-

-

-

-

-

91

57

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock on merger

9,175

0

0

0

2,540

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17

121

230

295

Cash acquired on merger

-

-

-

-

-

0

0

0

25,525

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosure of non-cash financing activity:
Issuance of warrants to placement agent’s representatives

453

0

0

0

100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock upon reverse merger, net of cash paid for partial shares

-

-

-

-

-

0

0

0

31,768

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of convertible promissory notes, related parties into common stock upon reverse merger

-

-

-

-

-

0

0

0

35,577

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock upon reverse merger, net of cash paid for partial shares

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of convertible promissory notes, related parties into common stock upon reverse merger

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification of convertible preferred stock warrant liability to equity

-

-

-

-

-

0

0

0

70

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities arising from obtaining right-of-use assets

-

-

-

-

-

-

-

-58

72

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition of property and equipment included in accounts payable

-

-

-

-

123

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-